Results 171 to 180 of about 118,558 (350)

Complications associated with subpalpebral lavage systems in upper and lower equine eyelids: A prospective, randomised study in 73 cases (2015–2024)

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Evidence for optimal location of subpalpebral lavage (SPL) systems is lacking. Objectives To compare the rate and types of complications with SPL systems located in central upper‐ compared with medial lower‐eyelid in hospitalised patients. Study Design Prospective, randomised treatment trial.
Annabelle E. Graham   +2 more
wiley   +1 more source

Evaluating associations of migraine‐related vertigo

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective We set out to examine detailed phenotypic data from our clinic for associations of vertigo in chronic migraine. Background Vertigo is a non‐canonical, common symptom of migraine. Little is known about its associations with other symptoms within the migraine phenotype.
Nazia Karsan   +7 more
wiley   +1 more source

Regression of conjunctival tumor during dietary treatment of celiac disease

open access: yesIndian Journal of Ophthalmology, 2010
A 3-year-old girl presented with a hemorrhagic conjunctival lesion in the right eye. The medical history revealed premature cessation of breast feeding, intolerance to the ingestion of baby foods, anorexia, and abdominal distention. Prior to her referral,
Tuncer Samuray   +2 more
doaj  

Biocompatibility of a Novel Microfistula Implant in Nonprimate Mammals for the Surgical Treatment of Glaucoma [PDF]

open access: yes, 2016
Ahmed, I I   +6 more
core   +2 more sources

Surgical management of the eyelid and bulbar conjunctiva in a patient with nevus of Ota [PDF]

open access: bronze, 2007
Felicidade Trindade   +2 more
openalex   +1 more source

Can atogepant be a preventive treatment for cluster headache?—Insights from a case series

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Cluster headache (CH) is a disabling primary headache disorder with limited therapeutic options. Calcitonin gene‐related peptide (CGRP) is known to be involved in CH pathophysiology; however, except for galcanezumab (300 mg) in episodic CH, anti‐CGRP monoclonal antibodies did not reduce CH attacks in randomized clinical trials. Atogepant is an
Catarina Serrão   +3 more
wiley   +1 more source

Syphilis of the Conjunctiva

open access: green, 1878
Charles Stedman Bull
openalex   +2 more sources

Home - About - Disclaimer - Privacy